TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Community
Main Feed
Today's Market Intel
Top Stocks
AI-Curated Stock Lists
IPO Calendar
Upcoming Listings
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
Stock Reports
AI Research Reports
Commentary
Opinionated Stock Takes
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Account
Plan, Billing & Appearance
Log inCreate Account
← Back to TickerSpark
▌Earnings Flash·October 21, 2026

Thermo Fisher Scientific Inc. (TMO) gains on earnings beats

Thermo Fisher Scientific Inc. (TMO) gains 1.6% after reporting earnings beats, as investors react positively to stronger-than-expected results and improved outlook.

Earnings FlashTMOHealthcareMedical - Diagnostics & Research
By TickerSpark·October 21, 2026·2 min read
Thermo Fisher Scientific Inc. (TMO) gains on earnings beats
▌Key Takeaway
Thermo Fisher Scientific Inc. (TMO) delivered a clean earnings beat, topping estimates on both EPS and revenue with $6.68 per share and $12.14 billion in sales. Shares rose 1.56% to $698.08, signaling a positive but measured investor response to another quarter of strong execution and a fifth straight EPS beat.

Thermo Fisher Scientific Inc. (TMO) Earnings Beat, Stock Gains

Thermo Fisher Scientific Inc. (TMO) beat estimates on both EPS and revenue, posting $6.68 per share and $12.14B, while shares gained 1.56% in regular-session trading to $698.08.

Key Numbers

  • EPS: $6.68 versus $6.40 estimated, a beat.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

Revenue: $12.14B versus $11.95B estimated, a beat.
  • Stock reaction: TMO closed at $698.08, up 1.56% from $687.37 in regular-session trading.
  • Trading activity: Shares ranged from $662.78 to $701.26. Volume was 1,328,089 versus a 2,157,682 average.
  • Consistency: TMO beat EPS estimates in each of its last five reported quarters, from 2025-10-22 through 2026-10-21.

    • A Clean Double Beat Extends TMO's Earnings Streak

    This is a clean double beat, not a single-line escape. Revenue cleared the estimate while EPS also exceeded its target, giving investors evidence of stronger-than-expected quarterly execution.

    The price response was positive but restrained. TMO closed at $698.08 against a $701.26 session high, while volume stayed below average at 1.33M shares versus 2.16M. That combination points to a favorable first read without heavy trading.

    The recent trend is the stronger signal. TMO has exceeded EPS estimates in five straight quarters, with actual EPS of $5.79, $6.57, $5.44, $6.03, and $6.68 across the listed periods. The earnings call's most useful role is connecting the $12.14B revenue result and $6.68 EPS performance to repeatable operating execution.

    Get AI research on any stock

    Instant reports, daily intelligence, and an AI analyst in your pocket.

    Get Started →

    Bottom Line

    TMO delivered a credible double beat and a five-quarter EPS outperformance streak, while the 1.56% gain offers a positive but measured market verdict.

    Read the full TMO research report
    ▌Common Questions

    Frequently asked questions

    +Did Thermo Fisher Scientific (TMO) beat earnings this quarter?
    Yes. Thermo Fisher Scientific reported EPS of $6.68 versus the $6.40 estimate and revenue of $12.14 billion versus the $11.95 billion estimate.
    +How did TMO stock react to the earnings report?
    TMO shares gained 1.56% in regular-session trading and closed at $698.08, up from $687.37. The stock traded between $662.78 and $701.26 during the session.
    +What does Thermo Fisher's earnings beat mean for investors?
    The report shows Thermo Fisher delivered a clean double beat, which supports the view that its operating execution remains strong. The market response was positive but restrained, suggesting investors viewed the quarter as solid rather than transformative.
    +Has Thermo Fisher Scientific beaten EPS estimates consistently?
    Yes. The company has beaten EPS estimates in each of its last five reported quarters, with actual EPS of $5.79, $6.57, $5.44, $6.03, and $6.68. That streak points to sustained earnings consistency.
    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

    Creates a free TickerSpark account — newsletter included.

    or with email

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌The Full Report

    Want the full picture on TMO?

    The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.

    Read the TMO report →Get Full Access →

    Not ready to subscribe? ·

    ▌The Full Report

    Get the full TMO research report

    • Analyst-grade deep dive
    • Charts, valuation, grades
    • Buy/sell price targets
    Read the TMO report →
    ▌For Active Investors

    Smarter research, on every ticker

    • Daily market intelligence
    • On-demand stock analysis
    • AI analyst chat
    Get Full Access →

    Cancel anytime

    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, free in your inbox.

    Creates a free TickerSpark account — newsletter included.

    or with email

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌More on TMO

    More to read

    All articles
    Thermo Fisher Scientific Inc. (TMO) gains on deep earnings beat
    TMO

    Thermo Fisher Scientific Inc. (TMO) gains on deep earnings beat

    Thermo Fisher Scientific Inc. (TMO) gained after a detailed Q3 2026 earnings beat, with stronger EPS, revenue, and margin expansion. The analysis goes beyond the headline, unpacking segment trends, guidance raises, and the tariff refund boost behind the move.

    Oct 21·7 min
    Thermo Fisher Scientific (TMO): Growth Quality Meets Rich Valuation
    TMO

    Thermo Fisher Scientific (TMO): Growth Quality Meets Rich Valuation

    Thermo Fisher is delivering strong revenue, margin, and EPS growth across its core life sciences businesses, but the stock already prices in much of the recovery. The report lands on a Hold as valuation and leverage limit upside from here.

    Oct 21·21 min
    Thermo Fisher Scientific Inc. (TMO) rises on deep earnings beat
    TMO

    Thermo Fisher Scientific Inc. (TMO) rises on deep earnings beat

    Thermo Fisher Scientific Inc. (TMO) rises after a broad Q2 beat, margin expansion, and a full-year guidance raise. This deep-dive examines the company’s share-gain narrative, end-market strength, five-quarter EPS beat streak, and what the stronger organic growth outlook could mean for the stock.

    Jul 23·9 min